» Articles » PMID: 33072090

Galectin-3 As a Therapeutic Target for NSAID-Induced Intestinal Ulcers

Overview
Journal Front Immunol
Date 2020 Oct 19
PMID 33072090
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03832946.

Citing Articles

Galectins and Liver Diseases.

Mimura S, Morishita A, Oura K, Takuma K, Nakahara M, Tadokoro T Int J Mol Sci. 2025; 26(2).

PMID: 39859504 PMC: 11766161. DOI: 10.3390/ijms26020790.


Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts.

Pineiro-Llanes J, Suzuki-Hatano S, Jain A, Venigalla S, Kamat M, Basso K Biomaterials. 2024; 315:122922.

PMID: 39509858 PMC: 11625619. DOI: 10.1016/j.biomaterials.2024.122922.


Link between mutations in and genes and chronic intestinal ulcers: A case report and review of literature.

Tang Y, Zhang J, Wang J, Tian R, Zhong W, Yao B World J Gastrointest Surg. 2024; 16(3):932-943.

PMID: 38577076 PMC: 10989323. DOI: 10.4240/wjgs.v16.i3.932.


The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target.

Zhou Z, Feng Z, Sun X, Wang Y, Dou G Int J Mol Sci. 2023; 24(21).

PMID: 37958500 PMC: 10649114. DOI: 10.3390/ijms242115516.


NSAID-Associated Small Intestinal Injury: An Overview From Animal Model Development to Pathogenesis, Treatment, and Prevention.

Zhang M, Xia F, Xia S, Zhou W, Zhang Y, Han X Front Pharmacol. 2022; 13:818877.

PMID: 35222032 PMC: 8864225. DOI: 10.3389/fphar.2022.818877.


References
1.
Chan Y, Lin H, Tu Z, Kuo Y, Hsu S, Lin C . Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions. Int J Mol Sci. 2018; 19(2). PMC: 5855614. DOI: 10.3390/ijms19020392. View

2.
Barondes S, Cooper D, Gitt M, Leffler H . Galectins. Structure and function of a large family of animal lectins. J Biol Chem. 1994; 269(33):20807-10. View

3.
Darnaud M, Dos Santos A, Gonzalez P, Augui S, Lacoste C, Desterke C . Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis. Gastroenterology. 2017; 154(4):1009-1023.e14. DOI: 10.1053/j.gastro.2017.11.003. View

4.
McCoy K, Geuking M, Ronchi F . Gut Microbiome Standardization in Control and Experimental Mice. Curr Protoc Immunol. 2017; 117:23.1.1-23.1.13. DOI: 10.1002/cpim.25. View

5.
Grabinger T, Garzon J, Hausmann M, Geirnaert A, Lacroix C, Hennet T . Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice. Front Microbiol. 2019; 10:1385. PMC: 6593069. DOI: 10.3389/fmicb.2019.01385. View